Of course it is... Congrats to longs.. But this is an extended release version of an old old old drug.. This won't last. I'll look to short soon..
Your market comments noted.. But here is the question I have... There are pretty good oral and topical estrogen ALREADY available for women and only 7% use them.. What's the advantage of having another estrogen on the market?
I wanna smoke what you guys are smoking. This "company" is "run" by corrupt thieves who hide behind lies and misleading statements. This will be sold for parts when they announce bankruptcy.
I agree with you 100%. They wll dilute shareholders again.. Unfortunately I missed the short at 118. I was greedy and waiting for 120. Now back down to 100.
Well.. We are sure glad that you have determined who can post here or not. Like a #$%$ dog marking the territory.. Get a life jakass and let healthy discussions go on. If you are not interested, why don't YOU take a hike?!! Bozo.
If I had a dollar for every successful phase I translating into an approved drug, I would be millionaire... By the way, genetically engineering a few cancer cells to produce internal antigens may not translate into immune recognition of the other cells.
Take a look at the date I posted, BOZO... Yes...I am a short. I did short at 120 and covered at 114 (stupidly.. kind of like you) and then again at 115 and covered early again unfortunately at 110 (again stupidly like you). I tried to short again at 107 but etrade wouldn't give me the shares short... I am not sure why.. So... I will tell you again.. This biotech will be worth nothing in a couple of years.. Looking for a short entry again... Will be back to tell you again.
The only good thing about this run up is that we can hopefully get a chance for shorting more before this "company" (and I use this term very very very loosely) goes bankrupt..... Which is not a question of IF but when!
I have said this in the past as well... Although I do think that the decline in the oil prices may be due to "coordinated" punishment of Russia for their new policies. The west wants to hit them hard and though this is going to be painful short term for oil drillers/producers, it is temporary in my opinion.
Having said that the shady management of this "company" has done an immaculate job of maintaining the valuation of this company in the billions despite not producing a single drop of oil or gas and in fact selling the only way they were making money by selling their refinery business...
This truly amazes me. But I know deep inside that in the next couple of years, this company WILL be bankrupt.
Nice post as always Bonk.
I wasn't lecturing.. It is perhaps better to so excellent response in myeloid neoplasms...JNJ and other pharma do throw money around sometimes since it is pocket change. It makes you more credible when you don't throw CURE for cancer. If Imetelstat can show a similar ongoing duration of response without significant adverse effects, then it makes #$%$ drugs like Jakafi obsolete. Thanks for directing me to the 8K.
Where did you find the 20%. And ...... when you say things like "cure for cancer", you really show your lack of understanding of the field... I would appreciate if you could point me to the 20% number. Thanks in advance
Do you guys know the royalty? I haven't seen the details and I am not about to comment on the potential.. Who knows.. Maybe like IMGN, GERN gave away everything for nominal fee. This is all about the details.. Even a blockbuster with poor royalties can be a failure.
God,,, What a totally nonsense statement.. Obviously you don't understand ibrutinib... The only reason this is not a 200 dollar + company is becuase their MANAGEMENT is clueless... The drug is a GAME CHANGER.
Yes.. You have been saying this for years.... more like 10 years.... and a few years from now it may be another 10 years.... when Oil wil be 10 dollars a barrel and renewables like wind, solar will probably be more in use...... Or exactly in 10 years, IOC will have drilled the area like swiss cheese and still would have found nothing... I will bet though that the stock price in ONE year will be at most half of what is now.